Related Experiment Video
Updated: Jun 27, 2026
09:43
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
An update on mortality in systemic lupus erythematosus
1Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Clinical and Experimental Rheumatology
|December 17, 2008
Summary
Systemic lupus erythematosus (SLE) survival has improved, but mortality remains a concern. Recent studies show disparities in lupus mortality based on ethnicity, socioeconomic status, age, and gender.
Area of Science:
- Rheumatology
- Immunology
- Public Health
Background:
- Systemic lupus erythematosus (SLE) and its treatments are associated with increased mortality.
- Recent research focuses on understanding lupus mortality trends over the past five years.
Purpose of the Study:
- To review recent studies on mortality rates in patients with systemic lupus erythematosus (SLE).
- To identify factors contributing to and disparities in SLE-related mortality.
Main Methods:
- A comprehensive literature search was conducted using PubMed.
- Focus was placed on articles published within the last five years concerning lupus mortality.
Main Results:
- Survival rates for SLE patients have significantly improved due to better management of disease manifestations, infections, and comorbidities.
- Despite improvements, significant disparities in mortality persist, influenced by ethnicity, socioeconomic status, age, and gender.
- Cardiovascular disease, infections, and severe disease activity remain primary causes of mortality in SLE patients.
Conclusions:
- Increased mortality in SLE patients continues to be a critical challenge in clinical management.
- Advances in treating SLE-associated infections and renal failure have not fully resolved the issue of elevated mortality rates.
